(Q35110913)

6 August 2017

1 reference

title

Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients (English)

1 reference

6 August 2017

0 references

Vincent C Emery

2

0 references

author name string

Duncan A Clark

series ordinal

1

1 reference

6 August 2017

Paul D Griffiths

series ordinal

3

1 reference

6 August 2017

publication date

1 April 2003

1 reference

6 August 2017

published in

Seminars in Hematology

1 reference

6 August 2017

volume

40

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

154-162

1 reference

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Presence and expression of human herpesvirus 6 in peripheral blood mononuclear cells of S100-positive, T cell chronic lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Case report: human herpesvirus 7 associated fatal encephalitis in a peripheral blood stem cell transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 6: relevance of infection in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

1 reference

7 January 2021

Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

The dynamics of human cytomegalovirus replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus-6 and human herpesvirus-7 in the bone marrow from healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Betaherpesviruses in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human cytomegalovirus persistence and latency in endothelial cells and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Latent human herpesvirus 6 infection of human monocytes/macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Studies of human antiviral CD8+ lymphocytes using class I peptide tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human beta-herpesvirus interactions in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

"Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

CMV and blood transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

The indirect effects of cytomegalovirus infection on the outcome of organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

CD46 is a cellular receptor for human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 7: another causal agent for roseola (exanthem subitum)

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 6 limbic encephalitis after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Comparison of antiviral compounds against human herpesvirus 6 and 7.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Productive infection of primary macrophages with human herpesvirus 7.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Determination and analysis of the complete nucleotide sequence of human herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2803%2970007-9

7 January 2021

10.1016/S0037-1963(03)70007-9

Identifiers

DOI

1 reference

6 August 2017

1 reference